Ozempic isalso approved to reduce the risk of heart attack, stroke, or death in adultswith type 2 diabetes mellitus and known heart disease.Wegovy injectionis approved to help adults and children aged 12 years and older with obesity orsome adults with excess weight (overweight), who also have weight-relatedmedical problems, to lose weight and keep the weight off, in addition to dietand exercise
Fasting serum insulin concentrations decreased significantly despite improved glycemic control, indicating enhanced tissue insulin sensitivity rather than merely increased insulin production
5 While injectable medications like Wegovy and Zepbound often achieve 15-20% weight loss 6,7 , the results of this trial are still clinically meaningful as a 10-15% reduction of body weight provides significant metabolic benefits
A threat to independent pharmacies in the USA Independent pharmacists in the US are stopping the sale of diabetes drug Ozempic because they are being underpaid by pharmacy benefits managers, according to a report by NBC
I was convinced that weight loss had to be miserable, but Willow proved me wrong
Legal Status and Future Outlook As of May 2026, Retatrutide remains investigational and is not yet FDA-approved for retail pharmaceutical distribution or general consumer use
